In just one week, Secaucus-based Quest Diagnostics announced two new product offerings: one for at-home consumer use and another for physicians. The consumer product, Genetic Insights, helps people ...
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...
The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...
Medical Device Network on MSN
Cleveland Diagnostics’ IsoPSA secures FDA approval for prostate cancer
The decision is supported by evidence from a clinical study and data from supporting analytical validation trials.
The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...
IsoPSA Test Evaluates Prostate Cancer-Specific Structural Variants of the PSA Protein to Aid in the Diagnosis of High-Grade Prostate Cancer ...
REDWOOD CITY, Calif., Oct. 3, 2012 /PRNewswire/ -- Ingenuity® Systems, a leading provider of biomedical information and analysis solutions, today announced a partnership with Life Technologies ...
The clinical diagnostic industry is on the verge of a recombinant protein revolution. Recombinants have been available for decades and have served some sectors of diagnostics quite well, but they have ...
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. VolitionRX, a life sciences company focused on developing blood-based diagnostic tests, today announced it has ...
The coronavirus pandemic has now impacted 192 countries and infected nearly 339,710 people globally. Many countries are in the containment stage. At this stage, simple measures like washing hands and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback